Princeton BioMolecular Research is a privately held company established in 1998. We design unigue small molecules and develop advanced tools for drug. Princeton BioMolecular Research is an experienced and reliable source of compounds for major pharmaceutical and agricultural companies. Our compound libraries are designed to possess drug-like properties. They are created using innovative technologies along with traditional medicinal chemistry principles. Mixing these technologies have streamlined an efficient synthesis while yielding highly pure compounds. Our technologies efficiently synthesize and highly pure compounds, while allowing rapid follow-up synthesis for lead development.